2nd November 2020 | RLMD - Relmada Therapeutics, Inc. | 3,000 | Open or private sale | 49,173 | $30.29 | $90,863.70 | $1,489,346.91 |
1st October 2020 | RLMD - Relmada Therapeutics, Inc. | 3,000 | Open or private sale | 52,173 | $37.99 | $113,955.60 | $1,981,801.84 |
28th December 2018 | AZRX - AzurRx BioPharma, Inc. | 7,500 | Grant/award etc. | 64,000 | $1.29 | $9,675.00 | $82,560.00 |
28th December 2018 | AZRX - AzurRx BioPharma, Inc. | 9,000 | Open or private purchase | 56,500 | $1.41 | $12,690.00 | $79,665.00 |
31st March 2019 | AZRX - AzurRx BioPharma, Inc. | 7,500 | Grant/award etc. | 71,500 | $2.42 | $18,150.00 | $173,030.00 |
13th June 2019 | AZRX - AzurRx BioPharma, Inc. | 30,000 | Grant/award etc. | 101,500 | $0.00 | | |
30th June 2019 | AZRX - AzurRx BioPharma, Inc. | 7,500 | Grant/award etc. | 79,000 | $1.70 | $12,750.00 | $134,300.00 |
9th August 2019 | ETON - Eton Pharmaceuticals, Inc. | 3,500 | Open or private purchase | 71,920 | $6.11 | $21,369.95 | $439,121.94 |
30th September 2019 | AZRX - AzurRx BioPharma, Inc. | 7,500 | Grant/award etc. | 86,500 | $0.60 | $4,500.00 | $51,900.00 |
24th December 2019 | RLMD - Relmada Therapeutics, Inc. | 2,388 | Payment by withholding | 61,484 | $40.64 | $97,048.32 | $2,498,709.76 |
24th December 2019 | RLMD - Relmada Therapeutics, Inc. | 3,706 | Payment by withholding | 63,872 | $40.64 | $150,611.84 | $2,595,758.08 |
24th December 2019 | RLMD - Relmada Therapeutics, Inc. | 21,094 | Exercise of derivative | 67,578 | $4.60 | $97,032.40 | $310,858.80 |
24th December 2019 | RLMD - Relmada Therapeutics, Inc. | 46,484 | Exercise of derivative | 46,484 | $3.24 | $150,608.16 | $150,608.16 |
31st December 2019 | AZRX - AzurRx BioPharma, Inc. | 7,500 | Grant/award etc. | 94,000 | $1.04 | $7,800.00 | $97,760.00 |
11th March 2020 | AZRX - AzurRx BioPharma, Inc. | 8,414 | Grant/award etc. | 116,998 | $1.04 | $8,750.56 | $121,677.92 |
11th March 2020 | AZRX - AzurRx BioPharma, Inc. | 14,584 | Grant/award etc. | 108,584 | $0.60 | $8,750.40 | $65,150.40 |
19th March 2020 | AZRX - AzurRx BioPharma, Inc. | 9,000 | Bona fide gift | 116,998 | $0.00 | | |
19th March 2020 | AZRX - AzurRx BioPharma, Inc. | 9,000 | Bona fide gift | 107,998 | $0.00 | | |
17th March 2020 | RLMD - Relmada Therapeutics, Inc. | 21,484 | Bona fide gift | 21,484 | $0.00 | | |
17th March 2020 | RLMD - Relmada Therapeutics, Inc. | 21,484 | Bona fide gift | 40,000 | $0.00 | | |
1st July 2020 | RLMD - Relmada Therapeutics, Inc. | 3,000 | Open or private sale | 37,000 | $43.89 | $131,677.20 | $1,624,018.80 |
3rd August 2020 | RLMD - Relmada Therapeutics, Inc. | 3,000 | Open or private sale | 34,000 | $35.74 | $107,213.40 | $1,215,085.20 |
18th August 2020 | RLMD - Relmada Therapeutics, Inc. | 2,189 | Payment by withholding | 58,173 | $39.03 | $85,436.67 | $2,270,492.19 |
18th August 2020 | RLMD - Relmada Therapeutics, Inc. | 26,362 | Exercise of derivative | 60,362 | $3.24 | $85,412.88 | $195,572.88 |
1st September 2020 | RLMD - Relmada Therapeutics, Inc. | 3,000 | Open or private sale | 55,173 | $34.74 | $104,206.80 | $1,916,467.26 |